Filing Flows › Agenus (AGEN) › Q2 2026 › vs Q2 2025
Agenus (AGEN) Q2 2026 vs Q2 2025 (year over year)
Agenus's revenue rose $8.8M (+34%) from $25.7M in Q2 2025 to $34.5M in Q2 2026. The biggest changes: Pre Commercial Product Revenue +$6.4M (—); Non Cash Royalty Revenue Related to the Sale of Future Royalties +$3.3M (+13%).
Agenus, Q2 2026: revenue $34.5M (+34% year over year), operating margin 32.7%, net loss $567K, operating cash flow −$31.2M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Non Cash Royalty Revenue Related to the Sale of Future Royalties | $28.1M | $24.8M | $3.3M | +13% |
| Pre Commercial Product Revenue | $6.4M | $0 | $6.4M | — |
| Revenue | $34.5M | $25.7M | $8.8M | +34% |
| Net loss | $567K | $30.0M | −$29.4M | -98% |
| Costs & expenses | $35.1M | $55.7M | −$20.6M | -37% |
| Operating costs | $23.2M | $42.4M | −$19.2M | -45% |
| Interest & other, net | $11.9M | $13.3M | −$1.4M | -11% |
| Research & development | $14.8M | $26.7M | −$12.0M | -45% |
| General & admin | $8.5M | $15.5M | −$7.1M | -45% |
| Operating cash sources | $35.3M | $27.0M | $8.3M | +31% |
| Depreciation & amortization | $517K | $3.2M | −$2.7M | -84% |
| Share-based compensation | $3.6M | $3.6M | $23K | +0.6% |
| Cash used in operations | $31.2M | $20.2M | $11.0M | +54% |
| Net loss absorbed | $567K | $30.0M | −$29.4M | -98% |
| Working capital & other | $34.8M | −$3.0M | $37.8M | — |
Questions
How much did Agenus's revenue grow year over year in Q2 2026?
Agenus's revenue rose $8.8M (+34%) from $25.7M in Q2 2025 to $34.5M in Q2 2026.
What drove Agenus's revenue change in Q2 2026?
Pre Commercial Product Revenue +$6.4M (—); Non Cash Royalty Revenue Related to the Sale of Future Royalties +$3.3M (+13%).